BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

0
Player Avatar jtimes2 (29.61) Submitted: 8/19/2009 3:41:54 PM : Outperform Start Price: $9.98 BCRX Score: -100.39

N1H1 Viris Drug

Featured Broker Partners


Advertisement